FIGO (International Federation of Gynecology and Obstetrics)
AbbreviationFIGO
Formation1954-07-26
HeadquartersFIGO House, Waterloo Court, 10 Theed Street, London, SE1 8ST, UK
Membership
132 Societies
President
Anne-Beatrice Kihara[1]
Websitewww.figo.org

The International Federation of Gynaecology and Obstetrics, usually just FIGO ("fee'go") as the acronym of its French name Fédération Internationale de Gynécologie et d'Obstétrique, is a worldwide non-governmental organisation representing obstetricians and gynaecologists in over one hundred territories. It was founded on 26 July 1954 in Geneva, Switzerland, to "promote the well-being of women and to raise the standard of practice in obstetrics and gynaecology". Membership is currently composed of 132 professional societies ('National Member Societies') of obstetricians and gynaecologists worldwide.

The headquarters of FIGO was initially located at Geneva, Switzerland. The FIGO Secretariat is located at London, United Kingdom.[2]

Core activities

The aim of FIGO is to improve the health and well-being of women and newborns worldwide. FIGO works to enable every woman to achieve active participation in her own health and rights, and the highest possible standards of health. It is financed by dues of member societies, grants, and educational activities.

FIGO's work covers many critical aspects of obstetrics and gynaecology and women's health and rights, including:

FIGO implements global programmes on specific women's health issues, in collaboration with National Member Societies and/or partner organisations. These include:

FIGO Committees and Working Groups are dedicated to critical sub-specialty issues across obstetrics, gynecology and related fields:

Classification systems

Uterine bleeding

Main article: FIGO classification of uterine bleeding
FIGO System 1 for uterine bleeding. The system for definition and nomenclature of normal and abnormal uterine bleeding (AUB) in the reproductive years.

In 2011, FIGO recognized two systems designed to aid research, education, and clinical care of women with abnormal uterine bleeding (AUB) in the reproductive years.

Ovarian cancer

Main article: Ovarian cancer § Staging

Ovarian cancer is staged using the FIGO staging system and uses information obtained after surgery, which can include a total abdominal hysterectomy via midline laparotomy, removal of (usually) both ovaries and fallopian tubes, (usually) the omentum, pelvic (peritoneal) washings, assessment of retroperitoneal lymph nodes (including the pelvic and para-aortic lymph nodes), appendectomy in suspected mucinous tumors, and pelvic/peritoneal biopsies for cytopathology.[3][4][5][6]

Publications

Major publications include:

World Congress of Gynecology and Obstetrics

FIGO conducts a triennial meeting, the World Congress of Obstetrics and Gynecology.[7] In addition the society sponsors fellowships, lectures, provides reports about women's health, and offers grants. Importantly through international committees consensus guidelines are achieved about evaluation and treatment of gynecological and obstetrical disorders.

German stamp, XI FIGO World Congress 1985
No Date City
II 22–28 June 1958 Montreal
V 23–30 September 1967 Sydney
VI April 1970 New York
VII August 1973 Moscow
VIII 17–22 October 1976 Mexico
IX 25–31 October 1979 Tokyo
X 17–22 October 1982 San Francisco
XI 15–20 September 1985 Berlin
XII October 1988 Rio de Janeiro
XIII August 1991 Singapore
XIV September 1994 Montreal
XV August 1997 Copenhagen
XVI August 2000 Washington DC
XVII 2–7 November 2003 Santiago
XVIII November 2006 Kuala Lumpur
XIX 4–9 October 2009 Cape Town
XX 7–12 October 2012 Rome
XXI 4-9 October 2015 Vancouver
XXII 14-19 October 2018 Rio de Janeiro
XXIV 9–12 October 2023 Paris

Member associations

This section is in list format but may read better as prose. You can help by converting this section, if appropriate. Editing help is available. (October 2018)

The following 124 professional societies are members of FIGO as of December 2010:

References

  1. ^ Samarasekera, Udani (6 October 2023). "Anne-Beatrice Kihara: taking the helm at FIGO". The Lancet. doi:10.1016/s0140-6736(23)02242-0. ISSN 0140-6736.
  2. ^ "FIGO". Retrieved 2010-12-19.
  3. ^ Jayson GC, Kohn EC, Kitchener HC, Ledermann JA (October 2014). "Ovarian cancer". Lancet. 384 (9951): 1376–88. doi:10.1016/S0140-6736(13)62146-7. PMID 24767708. S2CID 205971030.
  4. ^ Seiden MV (2012). "Gynecologic Malignancies". In Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J (eds.). Harrison's Principles of Internal Medicine (18th ed.). McGraw-Hill. ISBN 978-0-07-174889-6.
  5. ^ "Ovarian cancer". DynaMed. June 18, 2015. Archived from the original on June 21, 2015.
  6. ^ "Ovarian Cancer Staging" (PDF). Society for Gynecologic Oncology. 1 January 2014. Archived (PDF) from the original on 5 November 2014.
  7. ^ "Congress". Archived from the original on 2010-07-10. Retrieved 2010-12-19.

External links

Authority control databases
Categories